As of December 31, 2010, Adeona had approximately $2.6 million in cash in comparison to approximately $2.7 million on December 31, 2009. As of February 28, 2011, Adeona had around $6.0 million in cash, like the net proceeds of approximately $3.from the January of 2011 financing 7 million. ‘We continued to make significant progress in the clinical development of our product candidates for Alzheimer's disease and multiple sclerosis during 2010. We anticipate reporting results from individuals who have finished their 6 month follow-up in the Alzheimer'in April of 2011 s disease clinical study, and, if the clinical email address details are positive, we plan to further our commercialization efforts of reaZin while a prescription medical meals.And Sylvain Baruchel, M.D. At a healthcare facility for Sick Children. The research was funded by the National Tumor Institute of Canada, Canadian Stem Cell Network, McLaughlin Center for Molecular Medicine, The James Lilah and Birrell Money for Neuroblastoma Research, and the Sick Kids Basis. Identification of inhibitors for MDM2 ubiquitin ligase activity from natural products by a novel high throughput electrochemiluminescent display screen: Abstract C 55. Researchers laboring intensively to build up new therapeutics often turn to naturally produced molecules used by plants or microrganisms to ward off predators.